258 related articles for article (PubMed ID: 29528967)
1. Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders Workshop.
Rickels MR; Stock PG; de Koning EJP; Piemonti L; Pratschke J; Alejandro R; Bellin MD; Berney T; Choudhary P; Johnson PR; Kandaswamy R; Kay TWH; Keymeulen B; Kudva YC; Latres E; Langer RM; Lehmann R; Ludwig B; Markmann JF; Marinac M; Odorico JS; Pattou F; Senior PA; Shaw JAM; Vantyghem MC; White S
Transplantation; 2018 Sep; 102(9):1479-1486. PubMed ID: 29528967
[TBL] [Abstract][Full Text] [Related]
2. Defining outcomes for β-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop.
Rickels MR; Stock PG; de Koning EJP; Piemonti L; Pratschke J; Alejandro R; Bellin MD; Berney T; Choudhary P; Johnson PR; Kandaswamy R; Kay TWH; Keymeulen B; Kudva YC; Latres E; Langer RM; Lehmann R; Ludwig B; Markmann JF; Marinac M; Odorico JS; Pattou F; Senior PA; Shaw JAM; Vantyghem MC; White S
Transpl Int; 2018 Apr; 31(4):343-352. PubMed ID: 29453879
[TBL] [Abstract][Full Text] [Related]
3. Examination of the Igls Criteria for Defining Functional Outcomes of β-cell Replacement Therapy: IPITA Symposium Report.
Landstra CP; Andres A; Chetboun M; Conte C; Kelly Y; Berney T; de Koning EJP; Piemonti L; Stock PG; Pattou F; Vantyghem MC; Bellin MD; Rickels MR
J Clin Endocrinol Metab; 2021 Sep; 106(10):3049-3059. PubMed ID: 34061967
[TBL] [Abstract][Full Text] [Related]
4. Defining outcomes for beta cell replacement therapy: a work in progress.
Piemonti L; de Koning EJP; Berney T; Odorico JS; Markmann JF; Stock PG; Rickels MR
Diabetologia; 2018 Jun; 61(6):1273-1276. PubMed ID: 29511779
[TBL] [Abstract][Full Text] [Related]
5. Continuous glucose monitoring after islet transplantation in type 1 diabetes: an excellent graft function (β-score greater than 7) Is required to abrogate hyperglycemia, whereas a minimal function is necessary to suppress severe hypoglycemia (β-score greater than 3).
Vantyghem MC; Raverdy V; Balavoine AS; Defrance F; Caiazzo R; Arnalsteen L; Gmyr V; Hazzan M; Noël C; Kerr-Conte J; Pattou F
J Clin Endocrinol Metab; 2012 Nov; 97(11):E2078-83. PubMed ID: 22996144
[TBL] [Abstract][Full Text] [Related]
6. Islet Transplantation Provides Superior Glycemic Control With Less Hypoglycemia Compared With Continuous Subcutaneous Insulin Infusion or Multiple Daily Insulin Injections.
Holmes-Walker DJ; Gunton JE; Hawthorne W; Payk M; Anderson P; Donath S; Loudovaris T; Ward GM; Kay TW; OʼConnell PJ
Transplantation; 2017 Jun; 101(6):1268-1275. PubMed ID: 27490410
[TBL] [Abstract][Full Text] [Related]
7. Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement.
Bartlett ST; Markmann JF; Johnson P; Korsgren O; Hering BJ; Scharp D; Kay TW; Bromberg J; Odorico JS; Weir GC; Bridges N; Kandaswamy R; Stock P; Friend P; Gotoh M; Cooper DK; Park CG; OʼConnell P; Stabler C; Matsumoto S; Ludwig B; Choudhary P; Kovatchev B; Rickels MR; Sykes M; Wood K; Kraemer K; Hwa A; Stanley E; Ricordi C; Zimmerman M; Greenstein J; Montanya E; Otonkoski T
Transplantation; 2016 Feb; 100 Suppl 2(Suppl 2):S1-44. PubMed ID: 26840096
[No Abstract] [Full Text] [Related]
8. Benefits of Islet Transplantation as an Alternative to Pancreas Transplantation: Retrospective Study of More Than 10 Ten Years of Experience in a Single Center.
Voglová B; Zahradnická M; Girman P; Kríž J; Berková Z; Koblas T; Vávrová E; Németová L; Kosinová L; Habart D; Fábryová E; Dovolilová E; Leontovyc I; Neškudla T; Peregrin J; Kovác J; Lipár K; Kocík M; Marada T; Svoboda J; Saudek F
Rev Diabet Stud; 2017; 14(1):10-21. PubMed ID: 28632818
[TBL] [Abstract][Full Text] [Related]
9. Successful islet transplantation: continued insulin reserve provides long-term glycemic control.
Ryan EA; Lakey JR; Paty BW; Imes S; Korbutt GS; Kneteman NM; Bigam D; Rajotte RV; Shapiro AM
Diabetes; 2002 Jul; 51(7):2148-57. PubMed ID: 12086945
[TBL] [Abstract][Full Text] [Related]
10. Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry.
Chetboun M; Drumez E; Ballou C; Maanaoui M; Payne E; Barton F; Kerr-Conte J; Vantyghem MC; Piemonti L; Rickels MR; Labreuche J; Pattou F;
Lancet Diabetes Endocrinol; 2023 Jun; 11(6):391-401. PubMed ID: 37105208
[TBL] [Abstract][Full Text] [Related]
11. Primary graft function, metabolic control, and graft survival after islet transplantation.
Vantyghem MC; Kerr-Conte J; Arnalsteen L; Sergent G; Defrance F; Gmyr V; Declerck N; Raverdy V; Vandewalle B; Pigny P; Noel C; Pattou F
Diabetes Care; 2009 Aug; 32(8):1473-8. PubMed ID: 19638525
[TBL] [Abstract][Full Text] [Related]
12. Predictive Value of C-Peptide Measures for Clinical Outcomes of β-Cell Replacement Therapy in Type 1 Diabetes: Report From the Collaborative Islet Transplant Registry (CITR).
Baidal DA; Ballou CM; Rickels MR; Berney T; Pattou F; Payne EH; Barton FB; Alejandro R;
Diabetes Care; 2023 Apr; 46(4):697-703. PubMed ID: 36657975
[TBL] [Abstract][Full Text] [Related]
13. Effect of Dapagliflozin on Glycemic Variability in Patients with Type 2 Diabetes under Insulin Glargine Combined with Other Oral Hypoglycemic Drugs.
Luo M; Kong X; Wang H; Zhai X; Cai T; Ding B; Hu Y; Jing T; Su X; Li H; Ma J
J Diabetes Res; 2020; 2020():6666403. PubMed ID: 33299890
[TBL] [Abstract][Full Text] [Related]
14. Long-term function (6 years) of islet allografts in type 1 diabetes.
Alejandro R; Lehmann R; Ricordi C; Kenyon NS; Angelico MC; Burke G; Esquenazi V; Nery J; Betancourt AE; Kong SS; Miller J; Mintz DH
Diabetes; 1997 Dec; 46(12):1983-9. PubMed ID: 9392484
[TBL] [Abstract][Full Text] [Related]
15. Islets isolated from donors with elevated HbA1c can be successfully transplanted.
Koh A; Kin T; Imes S; Shapiro AM; Senior P
Transplantation; 2008 Dec; 86(11):1622-4. PubMed ID: 19077899
[TBL] [Abstract][Full Text] [Related]
16. First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 6: patient selection for pilot clinical trials of islet xenotransplantation.
Hering BJ; O'Connell PJ
Xenotransplantation; 2016; 23(1):60-76. PubMed ID: 26918540
[TBL] [Abstract][Full Text] [Related]
17. International trial of the Edmonton protocol for islet transplantation.
Shapiro AM; Ricordi C; Hering BJ; Auchincloss H; Lindblad R; Robertson RP; Secchi A; Brendel MD; Berney T; Brennan DC; Cagliero E; Alejandro R; Ryan EA; DiMercurio B; Morel P; Polonsky KS; Reems JA; Bretzel RG; Bertuzzi F; Froud T; Kandaswamy R; Sutherland DE; Eisenbarth G; Segal M; Preiksaitis J; Korbutt GS; Barton FB; Viviano L; Seyfert-Margolis V; Bluestone J; Lakey JR
N Engl J Med; 2006 Sep; 355(13):1318-30. PubMed ID: 17005949
[TBL] [Abstract][Full Text] [Related]
18. Comparative impact on islet isolation and transplant outcome of the preservation solutions Institut Georges Lopez-1, University of Wisconsin, and Celsior.
Niclauss N; Wojtusciszyn A; Morel P; Demuylder-Mischler S; Brault C; Parnaud G; Ris F; Bosco D; Badet L; Benhamou PY; Berney T
Transplantation; 2012 Apr; 93(7):703-8. PubMed ID: 22343333
[TBL] [Abstract][Full Text] [Related]
19. Islet transplantation as safe and efficacious method to restore glycemic control and to avoid severe hypoglycemia after donor organ failure in pancreas transplantation.
Gerber PA; Hochuli M; Benediktsdottir BD; Zuellig RA; Tschopp O; Glenck M; de Rougemont O; Oberkofler C; Spinas GA; Lehmann R
Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29140547
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of an intrinsic relationship between endogenous C-peptide concentration and determinants of glycemic control in type 1 diabetes following islet transplantation.
Brooks AM; Oram R; Home P; Steen N; Shaw JA
Diabetes Care; 2015 Jan; 38(1):105-12. PubMed ID: 25422169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
